Research programme: CFTR mRNA therapeutics - Translate Bio
Latest Information Update: 28 Nov 2024
Price :
$50 *
At a glance
- Originator Translate Bio
- Class Antifibrotics; RNA
- Mechanism of Action Cystic fibrosis transmembrane conductance regulator stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cystic fibrosis